IRCT20230809059105N1招募中Unknown
A double-blind randomized placebo - controlled trial of melatonin as premedication agent in Caesarean section
Alayen universty0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- Female
入选标准
- •The study's inclusion criteria encompassed individuals who fulfilled the subsequent requirements: age exceeding 18 years, categorized as ASA I or ASA II (pertaining to the American Society of Anesthesiologists Physical Status Classification System, signifying a patient in good health or with mild systemic illness, respectively), pregnancy at a gestational age surpassing 37 weeks, unbroken membranes, scheduled surgical procedures, patient agreement and contentment with study participation, and women with a solitary pregnancy.
排除标准
- •The exclusion criteria for the study encompass several factors, including ASA III or higher, which indicates severe systemic disease or a constant threat to life, documented drug allergy to melatonin or any other study medications, contraindications for spinal anesthesia such as spinal abnormalities or infections, inability of the patient to respond or demonstrate awareness to the questions rose, a history of mental or neurological diseases that could affect the patient's ability to participate or comprehend the study procedures, addiction to substances that could interfere with the study outcomes, disapproval or dissatisfaction expressed by the patient regarding their involvement in the study, presence of congenital malformations in the fetus detected during routine prenatal screening, inability to provide informed consent due to intellectual impairment or other factors, significant heart disease that could pose additional risks during the surgical procedure.
研究者
相似试验
尚未招募
4 期
A study to observe the effect of therapeutic doses of Diazepam among healthy individuals using stop signal reaction timeCTRI/2020/02/023530Institute of Neurosciences Kolkata
尚未招募
3 期
A Randomized Double-blinded Placebo-controlled Trial of Prophylactic Rectal Indomethacin for Prevention of Post-embolization Syndrome in Patients with Hepatocellular CarcinomaPost-embolization syndromeRectal indomethacinTACEInterleukin-6Interleukin-13TNF-alphaICAM-1Hepatocellular carcinomaTCTR20210209002In process for Ratchadaphiseksomphot Endowment Fund submission120
已完成
3 期
PTX and Contrast Induced Nephropathypatients candidate for percutaneous coronary intervention.???????? ???? ??? ?????? ???? ??????? ???? ??????? ? ??????IRCT2016111530905N1Imam Hossein Hospital110
已完成
不适用
Randomized controlled trial of antibiotics in children with chronic moist coughChronic (>3 weeks) moist cough in childrenRespiratory - Other respiratory disorders / diseasesACTRN12605000533695Department of Respiratory Medicine, Royal Children's Hospital60
已完成
不适用
A Randomised Placebo - Controlled Double Blind Trial Comparing 1) a Two Month Intensive Phase of Ethambutol, Moxifloxacin, Rifampicin, Pyrazinamide Versus the Standard Regimen (Ethambutol, Isoniazid, Rifampicin, Pyrazinamide) and 2) a Treatment Shortening Regimen Comparing Two Months Moxifloxacin, Isoniazid, Rifampicin, Pyrazinamide Followed by Two Months Moxifloxacin, Isoniazid, Rifampicin Versus the Standard Regimen (Two Months Ethambutol, Isoniazid, Rifampicin, Pyrazinamide Followed by Four Months Isoniazid and Rifampicin) for the Treatment of Adults With Pulmonary Tuberculosis-A15 Respiratory tuberculosis, bacteriologically and histologically confirmedRespiratory tuberculosis, bacteriologically and histologically confirmedA15PER-098-09niversity College London,